Antibiotic combination marketed by Abbott in India on list of banned drugs 13.03.2016 15:32 Reuters MUMBAI (Reuters) - A powerful antibiotic combination that is marketed in India by U.S. pharmaceutical giant Abbott Laboratories is among 344 drug combinations that have been banned by the Indian health authorities.
